Project Grant RF1NS133657

Award Date 9/1/23
Completion Date 8/31/26
Dollars Obligated $3.1M
Federal Grant Program
93.372
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded $3.6 million under the 21st Century Cures Act Brain Research through Advancing Innovative Neurotechnologies program (CFDA 93.372) to Stanford University. The project grant will support development of a noninvasive, dynamically programmable in vivo light source for rapid brain-wide optogenetic screening. Specifically, the awardee aims to develop mechanoluminescent nanoparticles with distinct emission...
This federal Project Grant award of $354,600.00 from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), will support the development of novel methodologies for simultaneous, distributed perturbation of multiple cortical regions using patterned light in head-fixed mice. The goal is to infer how large-scale patterns of cortical activity underlie...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded The Trustees of Columbia University in the City of New York, doing business as the Health Sciences Division, a $2,554,313 federal Project Grant under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372). The grant, which runs from Sep 1, 2023 to Aug 31, 2026, will support research to determine if targeted in vivo manipulations of local circuit control...
The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $9,213,665 Project Grant to the University of Texas Health Science Center at Houston (UTHealth) on September 19, 2023 to develop "Neural Recording and Simulation Tools to Address the Mesoscale Gap" under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853). This grant will fund research to advance understanding of the human brain by developing improved neural...
The University of Chicago received a $3.89 million Project Grant from the National Institutes of Health National Institute of Neurological Disorders and Stroke under the 21st Century Cures Act Brain Research through Advancing Innovative Neurotechnologies program. The grant will fund research from August 2022 through August 2025 to directly measure and manipulate the spiking activity of locus coeruleus and ventral tegmental area axons in the hippocampus of mice during hippocampal-dependent...
The U.S. National Institutes of Health (NIH) awarded a $1,671,116 Cooperative Agreement grant under the Trans-NIH Research Support (CFDA 93.310) program to The Washington University in St. Louis. The 3-year grant, running from September 2023 to August 2026, aims to develop a novel two-component optogenetic system for reversibly controlling the activity of user-defined synaptic connections between specific cell types in the brain. The project will involve engineering light-sensitive G...
The federal Project Grant award R01NS139872, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), supports the development of "photo-caged" designer receptor exclusively activated by designer drug (DREADD) agonists. These optochemogenetic tools are designed to enable site-specific and temporally-precise silencing of synaptic...
The University of Michigan was awarded a $2.7 million Trans-NIH Research Support Project Grant from the Department of Health and Human Services National Institutes of Health Office of the Director to develop new classes of optogenetic and chemogenetic tools with feedback control. The three-year award running from August 15, 2022 to August 14, 2025 will support the design of the first closed-loop chemogenetic tool with feedback control to suppress irregularly high neuronal activity, as well as...
This Project Grant award of $434,610 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports the development of light-triggered molecular tools critical for understanding the brain's neural network. The principal investigator, Dr. Nasri Nesnas of the Florida Institute of Technology, is collaborating with neuroscientists to design and use these tools to precisely manipulate calcium ion concentrations and enable temporal control of...
The National Institute of Neurological Disorders and Stroke (NINDS), a component of the National Institutes of Health (NIH), awarded a $597,844 Project Grant under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative program (CFDA 93.372) to The Regents of the University of California, San Francisco (UCSF). This 3-year project, effective September 1, 2024, aims to map the functional G-protein coupled receptor (GPCR) landscape in neurons...

The University of Texas Health Science Center at Houston (UTHealth) received a $3,145,118 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372). The grant aims to develop a new class of optogenetic tools based on natural potassium-selective channelrhodopsins (KCRs) that can precisely silence neuronal activity in both cell bodies and axons. This will address limitations of current inhibitory optogenetic tools, enabling improved understanding of neural circuit function and potential treatment of neurological disorders involving neuronal hyperexcitability. The three-year project will involve identifying and characterizing novel KCR homologs, engineering enhanced KCR variants, and optimizing KCR-based optogenetic inhibition in the mouse primary visual cortex and thalamocortical projections. This work is led by a team of experts in photobiology, system neuroscience, and protein engineering.

Generated 7/16/24, 8:32 AM